Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Computer Aided Biology Pioneer Synthace Secures $25.6M In Series B Funding
Venture Capital

Computer Aided Biology Pioneer Synthace Secures $25.6M In Series B Funding

by businesswire.com posted 11months ago 51 views
LONDON--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Automation?src=hash" target="_blank"gt;#Automationlt;/agt;--Synthace Ltd., the company behind the leading cloud software platform for automating and improving the success rate of biological research and development, today announced the closing of a $25.6m Series B financing round led by Horizons Ventures with additional investment from Luminous Ventures, SOSV and select other individual and large family office investors. Synthace will use the new funds to drive continued product development and build upon its cell and gene thera.

In this article